Menu
Log in
Forgot password
Log in
Forgot password

Literature Updates

  • Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophageal Adenocarcinoma: TRAP Study

    19 Feb 2020 11:16 AM | Deleted user

    Charlotte I. Stroes, Sandor Schokker, Aafke Creemers, Remco J. Molenaar, Maarten C.C.M. Hulshof, Stephanie O. van der Woude, Roel J. Bennink, Ron A.A. Mathôt, Kausilia K. Krishnadath, Cornelis J.A. Punt, Rob H.A. Verhoeven, Martijn G.H. van Oijen, Geert-Jan Creemers, Grard A.P. Nieuwenhuijzen, Maurice J.C. van der Sangen, Laurens V. Beerepoot, Joos Heisterkamp, Maartje Los, Marije Slingerland, Annemieke Cats, Geke A.P. Hospers, Maarten F. Bijlsma, Mark I. van Berge Henegouwen, Sybren L. Meijer, Hanneke W.M. van Laarhoven.

    Click here to read the full abstract.

  • Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201

    19 Feb 2020 11:13 AM | Deleted user

    Syma Iqbal, Shannon McDonough, Heinz-Josef Lenz, David Ilson, Barbara Burtness, Chaitali S. Nangia, Afsaneh Barzi, Charles J. Schneider, Jane Jijun Liu, Efrat Dotan, Katherine A. Guthrie, Howard S. Hochster.

    Click here to read the full abstract.

  • Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett’s Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study

    19 Feb 2020 11:10 AM | Deleted user

    Vinicius J. Campos, Guilherme S. Mazzini, José F. Juchem, Richard R. Gurski.

    Click here to read the full abstract.

  • Esophageal High-Resolution Manometry Can Unravel the Mechanisms by Which Different Bariatric Techniques Produce Different Reflux Exposures

    19 Feb 2020 11:07 AM | Deleted user

    Salvatore Tolone, Edoardo Savarino, Nicola de Bortoli, Marzio Frazzoni, Leonardo Frazzoni, Vincenzo Savarino, Ludovico Docimo.

    Click here to read the full abstract.

  • Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain

    27 Jan 2020 8:17 AM | Deleted user

    Tamar B. Nobel, Nikita Dave, Mahmoud Eljalby, Xinxin Xingg, Arianna Barbetta, Daniela Molena.

    Click here to read the full abstract.

  • Patient-Reported Symptoms for Esophageal Cancer Patients Undergoing Curative Intent Treatment

    27 Jan 2020 8:15 AM | Deleted user

    Vaibhav Gupta, Catherine Allen-Ayodabo, Laura Davis, Haoyu Zhao, Julie Hallet, Alyson L. Mahar, Jolie Ringash, Biniam Kidane, Gail Darling, Natalie G. Coburn.

    Click here to read the full abstract.

  • Using Benchmarking Standards to Evaluate Transition to Minimally Invasive Esophagectomy

    27 Jan 2020 8:12 AM | Deleted user

    Paul A. Carroll, Nithin Jacob, Jonathan C. Yeung, , Gail E. Darling.

    Click here to read the full abstract.

  • For Gastroesophageal Junction Cancers, Does an “Esophageal” or “Gastric” Surgical Approach Offer Better Perioperative and Oncologic Outcomes?

    20 Jan 2020 7:49 AM | Deleted user

    Jennifer Tseng, Mitchell C. Posner.

    Click here to read the full abstract.

  • Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis

    20 Jan 2020 7:47 AM | Deleted user

    Stephanie G. Worrell, Christopher W. Towe, Jennifer A. Dorth, Mitchell Machtay, Yaron Perry, Philip A. Linden.

    Click here to read the full abstract.

  • Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer

    20 Jan 2020 7:45 AM | Deleted user

    Yuichiro Nakashima, Hiroshi Saeki, Qingjiang Hu, Yasuo Tsuda, Yoko Zaitsu, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Eiji Oki, Masaki Mori.

    Click here to read the full abstract.

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software